Advertisement.

SPHRY Projected Dividend Yield

ADR (Sponsored)/Starpharma Holdings Ltd ( OTCBB : SPHRY )

Starpharma Holdings engaged in research, development and commercialization of dendrimer products for pharmaceutical, life-science and other applications. Activities within Co. is directed towards the development of precisely defined nanoparticles called dendrimers, including on the development of VivaGel® for the management and prevention of bacterial vaginosis, and as a condom coating. Co. is also applying its proprietary dendrimers to drug delivery. Co.'s Dendrimer Enhanced Product technology (DEP™) consists of: DEP® docetaxel, which is used for pancreatic cancer; DEP® cabazitaxel, which is used for prostate and ovarian cancer; and DEP® irinotecan, which is used for colon cancer.

20 YEAR PERFORMANCE RESULTS

SPHRY Dividend History Detail
SPHRY Dividend News
SPHRY Competitors News

# of Shares: 0

Closing Price: 0.75

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000